Terms: = Brain cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Diagnosis
12 results:
1. Clinical and Molecular Features of Patients with Gliomas Harboring IDH1 Non-canonical Mutations: A Systematic Review and Meta-Analysis.
Di Nunno V; Franceschi E; Tosoni A; Gatto L; Maggio I; Lodi R; Angelini D; Bartolini S; Brandes AA
Adv Ther; 2022 Jan; 39(1):165-177. PubMed ID: 34853984
[TBL] [Abstract] [Full Text] [Related]
2. Differential Expression of Hypoxia-Related Genes in Primary brain Tumors and Correlation with Clinicopathologic Data.
Bayat S; Mamivand A; Khoshnevisan A; Maghrouni A; Shabani S; Raouf MT; Yaseri M; Saffar H; Tabrizi M
World Neurosurg; 2021 Oct; 154():e465-e472. PubMed ID: 34303851
[TBL] [Abstract] [Full Text] [Related]
3. The relationship between MRI quantitative parameters and the expression of hypoxia inducible factor-1 alpha in cerebral astrocytoma.
Shu C; Wang J
Clin Neurol Neurosurg; 2017 Feb; 153():14-19. PubMed ID: 28006727
[TBL] [Abstract] [Full Text] [Related]
4. New developments in the pathogenesis and therapeutic targeting of the IDH1 mutation in glioma.
Dimitrov L; Hong CS; Yang C; Zhuang Z; Heiss JD
Int J Med Sci; 2015; 12(3):201-13. PubMed ID: 25678837
[TBL] [Abstract] [Full Text] [Related]
5. Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.
Berghoff AS; Ilhan-Mutlu A; Dinhof C; Magerle M; Hackl M; Widhalm G; Hainfellner JA; Dieckmann K; Pichler J; Hutterer M; Melchardt T; Bartsch R; Zielinski CC; Birner P; Preusser M
Neuropathol Appl Neurobiol; 2015 Feb; 41(2):e41-55. PubMed ID: 25256708
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic significance of Ki67 proliferation index, HIF1 alpha index and microvascular density in patients with non-small cell lung cancer brain metastases.
Berghoff AS; Ilhan-Mutlu A; Wöhrer A; Hackl M; Widhalm G; Hainfellner JA; Dieckmann K; Melchardt T; Dome B; Heinzl H; Birner P; Preusser M
Strahlenther Onkol; 2014 Jul; 190(7):676-85. PubMed ID: 24577133
[TBL] [Abstract] [Full Text] [Related]
7. Galectin-3: a novel protein in cerebellar hemangioblastoma.
Al-Salam S; Al-Salam M; Al Ashari M
Int J Clin Exp Pathol; 2013; 6(5):853-61. PubMed ID: 23638216
[TBL] [Abstract] [Full Text] [Related]
8. ["Vicious circles" of glioblastoma tumors: vascularization and invasiveness].
Szala S; Jarosz M; Smolarczyk R; Cichoń T
Postepy Hig Med Dosw (Online); 2012 Nov; 66():888-900. PubMed ID: 23175345
[TBL] [Abstract] [Full Text] [Related]
9. Breast cancer recurrence diagnosis suspected on tumor marker rising: value of whole-body 18FDG-PET/CT imaging and impact on patient management.
Champion L; Brain E; Giraudet AL; Le Stanc E; Wartski M; Edeline V; Madar O; Bellet D; Pecking A; Alberini JL
Cancer; 2011 Apr; 117(8):1621-9. PubMed ID: 21472709
[TBL] [Abstract] [Full Text] [Related]
10. Meta-analysis of glioblastoma multiforme versus anaplastic astrocytoma identifies robust gene markers.
Dreyfuss JM; Johnson MD; Park PJ
Mol Cancer; 2009 Sep; 8():71. PubMed ID: 19732454
[TBL] [Abstract] [Full Text] [Related]
11. Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene.
Bolignano D; Donato V; Lacquaniti A; Fazio MR; Bono C; Coppolino G; Buemi M
Cancer Lett; 2010 Feb; 288(1):10-6. PubMed ID: 19540040
[TBL] [Abstract] [Full Text] [Related]
12. Tumoral micro-blood vessels and vascular microenvironment in human astrocytic tumors. A transmission electron microscopy study.
Arismendi-Morillo G; Castellano A
J Neurooncol; 2005 Jul; 73(3):211-7. PubMed ID: 15980971
[TBL] [Abstract] [Full Text] [Related]
